Header Logo

Connection

ERIC JONASCH to Pemetrexed

Back to Details
This is a "connection" page, showing publications ERIC JONASCH has written about Pemetrexed.
ERIC JONASCH
Connection Strength
0.029
Pemetrexed
  1. Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol. 2013 Oct; 36(5):450-4.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.